CHICAGO (Reuters) - The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a ...

Lane Butts, a Spokane resident, is confronting the possibility of inheriting Huntington's disease, a genetic brain disease ...

The Human Domainome 1—the largest library of human protein variants—reveals the cause of certain genetic disorders, paving ...

CarePal, the parent company of Impact Guru, in its State of Cancer Fundraising Report 2024, revealed that the top 100 cancer ...

A risk prediction score that uses machine learning and a patient’s genetic information may identify autoimmune conditions up ...

For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts, dialysis and transplantation are among the only treatments. More than 12.

Lane Butts, a Spokane resident, is preparing to learn if he has inherited Huntington's disease, a genetic brain disorder ...

Shared decision-making forms an increasingly important part of the expert consultation for athletes with genetic heart ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts ...

None of the cell and gene therapies that reached the final regulatory submission stage were rejected by the FDA.

Eleven foals in the Pacific Northwest were diagnosed with a condition called Equine Juvenile Spinocerebellar Ataxia (EJSCA).